Tech Company M&A Transactions
EUSA Pharma Acquisition
Based in Langhorne, EUSA Pharma was acquired by Jazz Pharmaceuticals. Jazz Pharmaceuticals said the transaction price was $700 million.
Transaction Overview
Company Name
Acquired By
Announced On
4/27/2012
Transaction Type
M&A
Amount
$700,000,000
M&A Terms
The acquisition will be paid for with $650 million in cash and a potential $50 million milestone payable in cash.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
1717 Langhorne-Newtown Road 201
Langhorne, PA 19047
USA
Langhorne, PA 19047
USA
Phone
Website
Email Address
Overview
EUSA Pharma is a specialty pharmaceutical company with a strong and growing portfolio of specialized hospital medicines focused on oncology, pain control and critical care, which it markets predominantly in Europe and the US (as the company's name suggests).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bryan Morton
Chief Financial Officer
David Cook
Chief Medical Officer
Tim Corn
President
Jim Mitchum
VP - Bus. Development
Anuj Madhok
VP - General Counsel
Zoe Evans
VP - Human Resources
Brian Jackson
Browse more venture capital transactions:
Prev: 4/27/2012: CloudMine venture capital transaction
Next: 4/27/2012: OncoPep venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document every notable VC transaction. VC investment data records on this site are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs